Lucy Brorson, 18 months, plays in her home in Stafford on Tuesday, Aug. 18, 2015. Lucy has a rare form of epilepsy, Dravet syndrome, and her parents have started treating her with cannabis oil.
by
Amy Umble
The toddler lay in
the hospital bed, her leg twitching and eyes drooping. Her body was
reacting to a seizure attacking her brain, but little Lucy Brorson still
lifted her hand when her mother asked for a fist bump.
The 18-month-old
loves to gently knock knuckles as a form of greeting. Lucy also waves
hello, says “bye–bye” and a handful of other words.
But her parents fear her vocabulary will stop growing — or worse, still, disappear.
Lucy has Dravet syndrome, a rare
form of epilepsy that has her tiny body under siege from frequent
seizures. Her parents, Kimberly and Bendik, researched the condition and
discovered that many children die. Those who live often have severe
developmental and physical delays. About three-quarters develop some
form of autism.
“We were obviously devastated,” said Kimberly Brorson.
The Stafford County family first
began fighting back at the condition with a regimen of anti-seizure
drugs and benzodiazepines. But the seizures kept coming, and the parents
worried that Lucy would be damaged by both the neural activity and the
drugs that were supposed to quell the seizures.
This summer, they turned to an
experimental drug, one that has sparked controversy across the country.
Desperate families have turned to marijuana to treat conditions that
haven’t responded to traditional medicine.
The first seizure struck when
Lucy was 7 months old. Her mother stepped out of the room for a moment
and returned to find Lucy slumped over in her exercise saucer.
Kimberly called 911, and it took paramedics more than 30 minutes to calm the seizure.
Doctors chalked it up to a
febrile seizure, perhaps caused by a fever after a vaccination. Such
seizures alarm parents, but they don’t indicate a predilection for
epilepsy.
Two weeks later, the family was
on vacation in Texas when Lucy’s body began to shake. She was taken to
Cook Children’s Medical Center, a hospital with experience in Dravet
syndrome.
That geographical happenstance
helped the youngster, who was diagnosed with the condition just before
her first birthday. Many children with Dravet don’t receive a diagnosis
for years.
The early diagnosis helped the Brorsons learn more about their options.
They enrolled Lucy in the
Rappahannock Area Community Services Board’s early intervention program,
so she could receive periodic evaluations.
They started a battery of medications — some aimed at preventing seizures, others given to stop a seizure once it starts.
It’s hard to know if the
medicines work, because seizures usually start increasing around the
second birthday of a person with Dravet.
Lucy’s seizures have been
increasing. Some days, she has intense seizures that require a trip to
the hospital. Other days, the seizures are mild, noticeable only by the
twitching of an eyebrow or the trembling of a leg.
“If you aren’t paying attention, you’ll miss it,” her mother said.
But each seizure affects Lucy’s brain, and the damage could be permanent.
Kimberly Brorson wanted to
prevent as many seizures as she could. But she wondered about the
long-term affects of the benzodiazepines. Those psychoactive drugs can
lead to dependence.
“And there aren’t rehab facilities for these kids,” she said.
She turned to social media for support, finding Facebook groups for families fighting the rare form of epilepsy.
“I don’t know what I would do
without these people,” she said. “I can’t imagine going through this
five years ago, without this resource.”
On Facebook, she learned about
Charlotte’s Web, a formula of cannabis oil created for a little girl
with Dravet syndrome. The formulation was low in tetrahydrocannabinol
(THC), which provides the high marijuana users traditionally seek.
As Kimberly looked into cannabis oil, she discovered “a network of medical refugees” using marijuana to treat seizure disorders.
In Virginia, it’s legal to treat
epilepsy with the oil, but there are no dispensaries. So the family
orders it from outside the state.
The bottles of cannabis oil are
shipped discreetly. Each day, Lucy happily consumes drops of the green
liquid, which has a faint aroma of pot.
It’s too soon to know if the oil
is helping Lucy — or if it’s making a difference for the hundreds of
other American families turning to marijuana.
In a chart review of patients at
Children’s Hospital Colorado, about one-third of families using
marijuana to treat epilepsy noted a significant decrease in seizures,
said Dr. Kelly Knupp, pediatric neurologist and epileptologist.
The review included anecdotal
accounts of seizure activity, and not official measures in the form of
electroencephalograms, she said.
“I don’t think there’s a great understanding of this yet,” Knupp said.
And researchers don’t know why
marijuana would slow seizure activity. Still, for desperate parents like
the Brorsons, the drug represents a chance at life. Research shows that
in disorders like Dravet, the epilepsy is often medically
refractory—meaning the seizures won’t respond to traditional
medications. About 30 percent of epilepsy patients fall into this
category—and many Dravet patients do, Knupp said.
“This is a syndrome with poorly
controlled seizures,” Knupp said.
“Families are willing to try anything to make the seizures go away I certainly understand families feeling like they have to try everything for their child.”
“Families are willing to try anything to make the seizures go away I certainly understand families feeling like they have to try everything for their child.”
Research of epilepsy and medical
marijuana is taking off, and there may be more answers soon. The FDA has
approved two studies of pharmaceutical grade cannabis oil, which could
provide a more scientific understanding of how the drug interacts with
seizures and how it affects children.
At this point, there is little
information on either. Some studies have shown that recreational
marijuana use does have a negative impact on adolescent brains, but it’s
not known if cannabis without THC would also interfere with brain
development.
Additionally, with no FDA
oversight of cannabis, parents don’t always know what’s in the bottles
they receive, Knupp said. An FDA sample study showed that many of the
formulations didn’t “contain what they reported to contain,” she said.
Knupp recommends families using
medical marijuana keep careful records — including a seizure diary,
regular EEGs and periodic lab screenings.
For the Brorsons, it’s too soon
to tell if Lucy is responding to the cannabis oil. But Kimberly Brorson
has high hopes for her daughter.
“It’s been difficult, but I
wouldn’t trade her for anything,” she said. “When you have a child who
is fighting for their life every single day, it changes your
perspective. We’ve learned a lot, and we’re connected to our community
in a new way.”
No comments:
Post a Comment